Search clinical trials for: 150 mg open-label secukinumab
Total 2932 results
-
Novartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsCompletedModerate to Severe Chronic Plaque-type PsoriasisUnited States, Hungary, Italy, Russian Federation, Germany, Czechia, Canada
-
Novartis PharmaceuticalsCompletedAnkylosing SpondylitisJapan
-
Novartis PharmaceuticalsCompletedModerate to Severe Plaque-type PsoriasisUnited States, Colombia, Estonia, Japan, Taiwan, Israel, Canada, Lithuania, Argentina, Latvia, Iceland, Mexico
-
Novartis PharmaceuticalsCompletedAnklyosing SpondylitisGermany, Austria, Spain, Switzerland, United Kingdom, United States, Singapore, Russian Federation, Netherlands, Italy, Finland, Czechia, Canada
-
Novartis PharmaceuticalsCompletedModerate to Severe Chronic Plaque-Type PsoriasisUnited States, Germany, Japan, Bulgaria, Czechia, Singapore, Switzerland, United Kingdom, Italy, France, Vietnam, Poland, Slovakia, Austria, Canada
-
Novartis PharmaceuticalsCompletedPsoriatic ArthritisUnited Kingdom, Germany, Italy, Spain, United States, Australia, Bulgaria, Russian Federation, Czechia, Canada, Netherlands, Switzerland, Puerto Rico
-
Novartis PharmaceuticalsCompletedModerate to Severe Plaque-type PsoriasisGermany, United States, Estonia, France, Canada
-
Novartis PharmaceuticalsCompletedAnkylosing SpondylitisGermany, Belgium, Netherlands, France, United States, Bulgaria, Italy, Russian Federation, Peru, United Kingdom, Canada, Mexico, Taiwan, Turkey
-
Novartis PharmaceuticalsRecruitingPolymyalgia RheumaticaUnited States, Australia, Germany, Belgium, France, Spain, Italy, Lebanon, Switzerland, Japan, Israel, Denmark, Argentina, Netherlands, Colombia, Chile, Hungary, Poland, Turkey, Czechia, Brazil, South Africa, Mexico, Canada, United Kingdom
-
Novartis PharmaceuticalsCompletedPsoriatic ArthritisGermany, United Kingdom, United States, Belgium, Philippines, Singapore, Thailand, Brazil, Czech Republic, Italy, Argentina, Israel, Russian Federation, Bulgaria, Romania, Australia, Canada, Poland, Slovakia
-
Novartis PharmaceuticalsCompletedModerate to Severe Palmoplantar PsoriasisBelgium, United States, Hungary, Russian Federation, Turkey, Australia, Israel, Netherlands, Portugal, Spain, United Kingdom, Norway, Slovakia, Canada, Finland
-
Novartis PharmaceuticalsCompletedPlaque PsoriasisChina, Thailand, Philippines, Turkey, Hungary, Malaysia
-
Novartis PharmaceuticalsCompletedPsoriatic ArthritisUnited States, Puerto Rico
-
Wake Forest University Health SciencesNovartisWithdrawnPyoderma Gangrenosum
-
Novartis PharmaceuticalsCompletedModerate to Severe Plaque-type PsoriasisUnited States, Czech Republic, Austria, Germany, India, Japan, Bulgaria, Singapore, Switzerland, United Kingdom, Italy, France, Poland, Slovakia, Canada, Vietnam
-
Novartis PharmaceuticalsCompletedSpondylitis, AnkylosingGermany, Austria, Denmark, United States, Australia, Netherlands, Poland, Italy, Bulgaria, Spain, Russian Federation, United Kingdom, Greece, Czechia, Canada, Norway, Slovakia, Switzerland, Finland
-
Oxford Cannabinoid Technologies Holdings PLCSimbec-Orion GroupCompleted
-
Novartis PharmaceuticalsActive, not recruitingGiant Cell Arteritis (GCA)United States, Belgium, Hungary, Italy, Turkey, Austria, Spain, Switzerland, France, Germany, Israel, Australia, Denmark, Greece, United Kingdom, Guatemala, Bulgaria, Czechia, Estonia, Argentina, Canada, Brazil, Sweden, Finland, Poland, P... and more
-
Mayo ClinicCompleted
-
Massachusetts General HospitalNational Center for Complementary and Integrative Health (NCCIH); Harvard UniversityCompletedMajor Depressive DisorderUnited States
-
Novartis PharmaceuticalsCompleted
-
PfizerPfizerRecruitingSickle Cell DiseaseUnited States, Nigeria
-
Universitätsklinikum Hamburg-EppendorfCompleted
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedSolid Tumor | Advanced Solid TumorSpain, United States, Netherlands, United Kingdom
-
Leiden UniversityCompleted
-
University of NebraskaRecruiting
-
OrphAI TherapeuticsCompletedAcute Myeloid Leukemia | OncologyUnited States
-
Scion NeuroStimEnrolling by invitationParkinson Disease | Parkinson's Disease and ParkinsonismUnited States
-
Impax Laboratories, LLCCompletedIdiopathic Parkinson's DiseaseUnited States
-
University of California, San FranciscoRecruiting
-
Rigel PharmaceuticalsNo longer availableImmune Thrombocytopenic Purpura
-
Henry Ford Health SystemPfizerTerminated
-
Warner ChilcottCompletedErectile DysfunctionUnited States
-
Mirum Pharmaceuticals, Inc.Completed
-
Alector Inc.Active, not recruitingFrontotemporal DementiaSpain, United States, Portugal, United Kingdom, France, Germany, Netherlands, Belgium, Australia, Italy, Turkey, Switzerland, Argentina, Canada, Greece, Sweden
-
Georgetown UniversityHackensack Meridian Health; Karyopharm Therapeutics IncTerminatedThymoma | Advanced Thymic Epithelial TumorUnited States
-
University Hospital, BordeauxNot yet recruitingBenign Prostatic Hypertrophy | Holmium Laser Enucleation of the Prostate
-
AstraZenecaParexelActive, not recruitingLocally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung CancerBelgium, United States, Canada, Poland, Romania, Taiwan, Thailand, Vietnam, France, Italy, Korea, Republic of, Brazil, Japan, Turkey, China, Malaysia, Germany, Spain, Australia, Hungary, Portugal, Switzerland, Israel, Philippines, Russian... and more
-
Studio Osteopatico Busto ArsizioRecruiting
-
University of Maryland, BaltimoreNot yet recruitingChronic Pain | Headache
-
Aldeyra Therapeutics, Inc.Recruiting
-
University of North Carolina, Chapel HillNational Institute of Allergy and Infectious Diseases (NIAID)CompletedFood HypersensitivityUnited States
-
Hospital de Egas MonizCompleted
-
MEI Pharma, Inc.SCRI Development Innovations, LLCCompleted
-
H. Lundbeck A/SCompleted
-
University of California, Los AngelesEnrolling by invitation
-
MEI Pharma, Inc.SCRI Development Innovations, LLCCompleted
-
Novartis PharmaceuticalsWithdrawn